Healthcare companies are basing solutions for a potential nursing shortage on the tech industry.

The event is scheduled for Tuesday, May 16, at the Le Meridien Hotel in Cambridge.

The two companies will combine digital platforms and health record systems to provide data on patient disease management.

The AI program can detect flags for suspected abdominal aortic aneurysms.

The platforms are designed to improve patient engagement and adherence.

Clinical trials for digital therapeutics have unique problems when it comes to collecting data, especially regarding adherence and efficacy. Gravine speaks with MDT about a new API from ObvioHealth that works to solve these issues.

Clario will now offer Strados' RESP™ Biosensor for the at-home capture of lung sounds.

MDT spoke with Harbison about the technology used at the 80th Street Residence in NYC that helps monitor the symptoms of patients with cognitive issues.

The trials are focused on a device which reportedly provides relief to migraine related pain and other symptoms.

Stanford Biodesign is a training platform for university students that is already supported by multiple industry leaders.

As the pharma industry relies more and more on smart phones and other connected devices, it's important to remember that not everyone has access to this technology.

The goal is to enable rapid screening and diagnostics of infectious diseases such as malaria and tuberculosis, which will be readily accessible to all population groups.

Rune Labs' StriveStudy platform and Emerald Innovations' Emerald wireless monitoring sensor will passively capture data on Parkinson's disease impact on function of 50 study participants in BlueRock's global non-interventional clinical study.

Dario set out to determine the effectiveness of deploying adapted machine learning to analyze and personalize user journeys in its DTx posture training solution.

PV is on the road to becoming a leader, not a follower, in leveraging drug lifecycle information for clinical trials and to inform clinical care

The new platform allows patients to access personalized cancer care.

New interactive tool, other resources help use regulatory strategy to drive successful business strategy for digital medical product development

Kaia Back Pain, a digital therapy for the treatment of non-specific acute, subacute and recurrent back pain, has been permanently added to the Directory of Digital Health Applications (DiGA)

US tops market, followed by China, Canada and Germany

Next-generation immersive mental health technology leverages virtual reality

Fiscal year 2024 budget includes improvements to medical device supply and shortage issues that negatively impact patients

Alira Health and MassMEDIC collaborated on the report.

The new API aims to collect more accurate information by utilizing techniques designed to avoid altering patient behavior.

Amsterdam logistics center strengthens links in the clinical trial supply chain, streamlines hybrid and DCT conduct.

The six-month EXCITE-HCM study of 70 patients will study the effects of exercise on electrical activity and blood flow using Vivalink’s medical wearable ECG sensor and cloud data services.

Five recipients of ActiGraph's Digital Endpoint Accelerator Research “DEAR” Grant to validate fit-for-purpose uses of DHTs in clinical populations have been announced.

The improvement of blood analysis technology and the dawn of decentralized trials have prompted development of at-home sampling products that draw from a capillary.

COPD digital app can now be prescribed by medical providers in Germany and will be covered by statutory health insurance.

Based on a broad portfolio of treatments by Novartis across many chronic diseases, the partnership will be taking a strategic approach to prioritize those diseases which are characterized by high levels of unmet patient needs.